Kandzi JD, Englisch A, Boeer B, Hahn M, et al. Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort Analysis. Clin Breast Cancer 2025 Oct 13:S1526-8209(25)00294.
PMID: 41233220